everolimus
Drug Details
- Generic Name
- everolimus
- Brand Names
- everolimus, EVEROLIMUS, Everolimus, Afinitor, Zortress, Afinitor Disperz
- Application Number
- ANDA219533
- Sponsor
- Novartis Pharma Stein AG
- NDC Codes
- 44
- Dosage Forms
- TABLET, TABLET, FOR SUSPENSION, POWDER
- Routes
- ORAL
- Active Ingredients
- EVEROLIMUS
Indications and Usage
1 INDICATIONS AND USAGE Everolimus tablets for oral suspension are kinase inhibitor indicated for the treatment of adult and pediatric patients aged 1 year and older with TSC who have subependymal giant cell astrocytoma (SEGA) that requires therapeutic intervention but cannot be curatively resected. ( 1.5 ) 1.5 Tuberous Sclerosis Complex (TSC)-Associated Subependymal Giant Cell Astrocytoma (SEGA) Everolimus tablets for oral suspension are indicated in adult and pediatric patients aged 1 year and older with TSC for the treatment of SEGA that requires therapeutic intervention but cannot be curatively resected.